NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Clinical Laserthermia Systems AB (publ) (ST: CLS-B)

 
CLS-B Technical Analysis
5
As on 9th Jun 2023 CLS-B STOCK Price closed @ 0.39 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2.77 & Strong Sell for SHORT-TERM with Stoploss of 3.74 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

CLS-BSTOCK Price

Open 0.38 Change Price %
High 0.45 1 Day 0.01 2.63
Low 0.38 1 Week 0.02 5.41
Close 0.39 1 Month -0.75 -65.79
Volume 1649988 1 Year -3.54 -90.08
52 Week High 4.22 | 52 Week Low 0.33
 
ST Sweden Most Active Stocks
QUIA 0.02 0.00%
QLIFE 0.04 0.00%
SBB-B 5.38 3.07%
STRLNG 0.12 33.33%
LUNE 21.97 6.65%
SAS 0.36 5.88%
URBIT 0.02 0.00%
IDOGEN 0.15 -31.82%
STAR-B 0.89 -1.11%
TELIA 24.60 0.41%
 
ST Sweden Top Gainers Stocks
S2M 0.52 100.00%
NETM-B 1.35 42.11%
STRLNG 0.12 33.33%
IVACC 7.26 32.97%
SPRINT 0.63 16.67%
TH1NG 1.61 16.67%
ATIC 5.14 15.77%
ATIC 5.14 15.77%
CIRCHE 3.69 15.67%
AXIC-A 8.16 15.25%
 
ST Sweden Top Losers Stocks
IDOGEN 0.15 -31.82%
IMMU 0.72 -27.27%
ALLR 1.55 -26.54%
MIDW-A 24.80 -22.98%
KILI 0.76 -16.48%
FRACTL 36.80 -14.02%
DIVIO-B 0.13 -13.33%
ZZ-B 41.50 -12.08%
LIPI 1.49 -11.83%
BACTI-B 72.70 -10.69%
 
 
CLS-B
Daily Charts
CLS-B
Intraday Charts
Whats New @
Bazaartrend
CLS-B
Free Analysis
 
CLS-B Important Levels Intraday
RESISTANCE0.52
RESISTANCE0.48
RESISTANCE0.45
RESISTANCE0.43
SUPPORT0.35
SUPPORT0.33
SUPPORT0.30
SUPPORT0.26
 
CLS-B Forecast April 2024
4th UP Forecast2.97
3rd UP Forecast2.14
2nd UP Forecast1.63
1st UP Forecast1.12
1st DOWN Forecast-0.34
2nd DOWN Forecast-0.85
3rd DOWN Forecast-1.36
4th DOWN Forecast-2.19
 
CLS-B Weekly Forecast
4th UP Forecast2.26
3rd UP Forecast1.66
2nd UP Forecast1.29
1st UP Forecast0.92
1st DOWN Forecast-0.14
2nd DOWN Forecast-0.51
3rd DOWN Forecast-0.88
4th DOWN Forecast-1.48
 
CLS-B Forecast2024
4th UP Forecast8.95
3rd UP Forecast6.2
2nd UP Forecast4.51
1st UP Forecast2.81
1st DOWN Forecast-2.03
2nd DOWN Forecast-3.73
3rd DOWN Forecast-5.42
4th DOWN Forecast-8.17
 
 
CLS-B Other Details
Segment EQ
Market Capital 305537600.00
Sector Healthcare
Industry Medical Devices
Offical website >
 
CLS-B Address
CLS-B
 
CLS-B Latest News
 
Your Comments and Response on Clinical Laserthermia Systems AB (publ)
 
CLS-B Business Profile
Clinical Laserthermia Systems AB (publ) develops and markets therapies, systems, and single-use instruments for thermal treatment of solid cancer tumors in Sweden. The company offers TRANBERG, a cancer immunotherapy system that includes a laser unit with unique monitoring capabilities and tailored single-use products primarily developed for imILT treatment; and applicator kit. It also is developing products for the treatment of breast, pancreatic, skin, and prostate cancers, as well as other solid cancer tumors. Clinical Laserthermia Systems AB (publ) has a collaboration agreement with Image Guided Therapy SA to develop and commercialize a software product for MR-generated temperature monitoring; collaborative license and co-development agreement with MRI Interventions, Inc. to provide navigation and laser ablation platforms for use in spine and neurosurgery; and clinical trial collaboration with Toronto General Hospital regarding MRI-guided laser ablation treatment of prostate cancer. The company is headquartered in Lund, Sweden. Address: Medicon Village, Lund, Sweden, 223 81
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service